Skip to content

Opening book details…

About this Medicine article

Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma by Peters, K. B.; Lou, E.; Desjardins, A.; Reardon, D. A.; Lipp, E. S.; Miller, E.; Herndon, J. E.; McSherry, F.; Friedman, H. S.; Vredenburgh, J. J. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Peters, K. B.; Lou, E.; Desjardins, A.; Reardon, D. A.; Lipp, E. S.; Miller, E.; Herndon, J. E.; McSherry, F.; Friedman, H. S.; Vredenburgh, J. J.
Publisher
Alphamed Press; AlphaMed Press Inc; Wiley (ISSN 1083-7159)
Published
2015
Field
Medicine (Health Sciences)

More by Peters, K. B.; Lou, E.; Desjardins, A.; Reardon, D. A.; Lipp, E. S.; Miller, E.; Herndon, J. E.; McSherry, F.; Friedman, H. S.; Vredenburgh, J. J.

Browse all works by Peters, K. B.; Lou, E.; Desjardins, A.; Reardon, D. A.; Lipp, E. S.; Miller, E.; Herndon, J. E.; McSherry, F.; Friedman, H. S.; Vredenburgh, J. J.